Intelligence · Clinical Development
Pipeline search results
Programs matching “administered” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 9 pipeline programs matching "administered" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Directly administered antiretroviral therapy (DAART)
BRIGHT MINDS BIOSCIENCES INC.
HIV Infections
2 trials -
ALN-TTR02 (patisiran) administered by intravenous (IV) infusion
Alnylam Netherlands B.V.
TTR-mediated Amyloidosis
1 trial -
BEAM-301: Single dose of BEAM-301 administered by IV
Beam Therapeutics
Glycogen Storage Disease Type Ia
1 trial -
Phase I Study of PM534 Administered to Patients with Advanced Solid Tumors
Lacuna Pharma Pty Ltd
Advanced Solid Tumors
1 trial -
Cardiovascular safety assessment of Tanimilast in healthy volunteers
Chiesi Farmaceutici S.p.A
This is Phase I study to assess the effect on the heart rate (HR) and cardiovascular safety according to electrocardiographic monitoring (including QT and QTc intervals) of CHF6001(Tanimilast) administered with NEXThaler® device in healthy adult volunteers.
1 trial -
Phase I Study of PM54 Administered to Patients with Advanced Solid Tumors
Lacuna Pharma Pty Ltd
Selected Advanced Solid Tumors
1 trial -
Treatment A-Bemnifosbuvir/Ruzasvir FDC administered fasting
Atea Pharmaceuticals
Healthy Volunteer Study
1 trial -
Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
SARS-CoV-2 Infection
1 trial -
KCHRF-DASH-AF-0002
Rhythm Pharmaceuticals Netherlands B.V.
Arrhythmias, Cardiac
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.